These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 8610411)
1. Rescue therapy with tacrolimus after combined kidney/pancreas and isolated pancreas transplantation in patients with severe cyclosporine nephrotoxicity. Hariharan S; Munda R; Cavallo T; Demmy AM; Schroeder TJ; Alexander JW; First MR Transplantation; 1996 Apr; 61(8):1161-5. PubMed ID: 8610411 [TBL] [Abstract][Full Text] [Related]
2. A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. Gruessner RW; Burke GW; Stratta R; Sollinger H; Benedetti E; Marsh C; Stock P; Boudreaux JP; Martin M; Drangstveit MB; Sutherland DE; Gruessner A Transplantation; 1996 Jan; 61(2):261-73. PubMed ID: 8600635 [TBL] [Abstract][Full Text] [Related]
3. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224 [TBL] [Abstract][Full Text] [Related]
4. Rescue therapy with tacrolimus in simultaneous pancreas/kidney transplantation. Becker G; Witzke O; Friedrich J; Albrecht KH; Wagner K; Philipp T; Heemann U Transpl Int; 1997; 10(1):51-4. PubMed ID: 9002152 [TBL] [Abstract][Full Text] [Related]
5. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
6. Use of tacrolimus eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantation. Peddi VR; Kamath S; Munda R; Demmy AM; Alexander JW; First MR Clin Transplant; 1998 Oct; 12(5):401-5. PubMed ID: 9787948 [TBL] [Abstract][Full Text] [Related]
7. Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients. Katari SR; Magnone M; Shapiro R; Jordan M; Scantlebury V; Vivas C; Gritsch A; McCauley J; Starzl T; Demetris AJ; Randhawa PS Clin Transplant; 1997 Jun; 11(3):237-42. PubMed ID: 9193849 [TBL] [Abstract][Full Text] [Related]
11. Prospective clinical trial comparing two immunosuppressive regimens, tacrolimus and mycophenolate mofetil versus everolimus and low-dose cyclosporine, in de novo renal transplant recipients: results at 6 months follow-up. Favi E; Citterio F; Spagnoletti G; Gargiulo A; Delreno F; Romagnoli J; Castagneto M Transplant Proc; 2009 May; 41(4):1152-5. PubMed ID: 19460503 [TBL] [Abstract][Full Text] [Related]
12. Increased early rejection rate after conversion from tacrolimus in kidney and pancreas transplantation. Barone GW; Ketel BL; Abul-Ezz SR; Lightfoot ML JOP; 2002 Mar; 3(2):49-53. PubMed ID: 11884766 [TBL] [Abstract][Full Text] [Related]
13. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras. Nankivell BJ; PʼNg CH; OʼConnell PJ; Chapman JR Transplantation; 2016 Aug; 100(8):1723-31. PubMed ID: 27306529 [TBL] [Abstract][Full Text] [Related]
14. Conversion from tacrolimus to cyclosporine could improve control of posttransplant diabetes mellitus after renal transplantation. Ramos-Cebrián M; Torregrosa JV; Gutiérrez-Dalmau A; Oppenheimer F; Campistol JM Transplant Proc; 2007 Sep; 39(7):2251-3. PubMed ID: 17889154 [TBL] [Abstract][Full Text] [Related]
15. How best to use tacrolimus (FK506) for treatment of steroid- and OKT3-resistant rejection after renal transplantation. Eberhard OK; Kliem V; Oldhafer K; Schlitt HJ; Pichlmayr R; Koch KM; Brunkhorst R Transplantation; 1996 May; 61(9):1345-9. PubMed ID: 8629294 [TBL] [Abstract][Full Text] [Related]
16. One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus. Chamienia A; Biedunkiewicz B; Król E; Debska-Slizień A; Rutkowski B Transplant Proc; 2006; 38(1):81-5. PubMed ID: 16504670 [TBL] [Abstract][Full Text] [Related]
17. Improved solitary pancreas transplant graft survival in the modern immunosuppressive era. Odorico JS; Becker YT; Groshek M; Werwinski C; Becker BN; Pirsch JD; Sollinger HW Cell Transplant; 2000; 9(6):919-27. PubMed ID: 11202579 [TBL] [Abstract][Full Text] [Related]
18. Thymoglobulin, sirolimus, and reduced-dose cyclosporine provides excellent rejection prophylaxis for pancreas transplantation. Knight RJ; Kerman RH; Zela S; Podder H; Van Buren CT; Katz S; Kahan BD Transplantation; 2003 Apr; 75(8):1301-6. PubMed ID: 12717220 [TBL] [Abstract][Full Text] [Related]
19. Conversion of renal transplant recipients from cyclosporin to low-dose tacrolimus for refractory rejection. Morris-Stiff G; Talbot D; Balaji V; Baboolal K; Callanan K; Hails J; Moore R; Manas D; Lord R; Jurewicz WA Transpl Int; 1998; 11 Suppl 1():S78-81. PubMed ID: 9664949 [TBL] [Abstract][Full Text] [Related]
20. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]